- Home
- SUPN vs BBUC Comparison
SUPN vs BBUC Comparison
Compare SUPN & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- BBUC
- Stock Information
- Founded
- SUPN 2005
- BBUC 2022
- Country
- SUPN United States
- BBUC United States
- Employees
- SUPN N/A
- BBUC N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- BBUC
- Sector
- SUPN Health Care
- BBUC
- Exchange
- SUPN Nasdaq
- BBUC Nasdaq
- Market Cap
- SUPN 2.6B
- BBUC 2.4B
- IPO Year
- SUPN 2012
- BBUC N/A
- Fundamental
- Price
- SUPN $54.61
- BBUC $36.68
- Analyst Decision
- SUPN Strong Buy
- BBUC
- Analyst Count
- SUPN 3
- BBUC 0
- Target Price
- SUPN $62.67
- BBUC N/A
- AVG Volume (30 Days)
- SUPN 725.2K
- BBUC 202.9K
- Earning Date
- SUPN 11-04-2025
- BBUC 11-06-2025
- Dividend Yield
- SUPN N/A
- BBUC 0.68%
- EPS Growth
- SUPN 1411.53
- BBUC N/A
- EPS
- SUPN 1.14
- BBUC N/A
- Revenue
- SUPN $665,125,000.00
- BBUC $8,240,000,000.00
- Revenue This Year
- SUPN $7.31
- BBUC N/A
- Revenue Next Year
- SUPN $21.87
- BBUC N/A
- P/E Ratio
- SUPN $46.18
- BBUC N/A
- Revenue Growth
- SUPN 5.55
- BBUC 6.96
- 52 Week Low
- SUPN $29.16
- BBUC $21.52
- 52 Week High
- SUPN $53.28
- BBUC $37.89
- Technical
- Relative Strength Index (RSI)
- SUPN 78.22
- BBUC 58.33
- Support Level
- SUPN $49.95
- BBUC $34.51
- Resistance Level
- SUPN $52.15
- BBUC $36.94
- Average True Range (ATR)
- SUPN 1.36
- BBUC 1.41
- MACD
- SUPN 0.30
- BBUC 0.02
- Stochastic Oscillator
- SUPN 97.61
- BBUC 76.40
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares
Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.